Label Image (Lbl500906571)
Trulicity Injection, Solution
Product Images NDC 50090-6571
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 48 technical images submitted to the FDA as part of the official labeling for Trulicity (NDC 50090-6571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Logo)
Qr Code (Qr V1)
Figure (Trulicity Ifu 0point75 Injection Sites Back V1)
Figure (Trulicity Ifu 0point75 Injection Sites Front V1)
Figure (Trulicity Ifu 1point5 Injection Sites Back V1)
Figure (Trulicity Ifu 1point5 Injection Sites Front V1)
Figure (Trulicity Ifu 3mg Injection Sites V1)
Figure (Trulicity Ifu 4point5mg Injection Sites V1)
Figure (Trulicity Ifu Check V1)
Exclamation (Trulicity Ifu Exclamation V1)
Figure (Trulicity Ifu Expiration Location V2)
Figure (Trulicity Ifu Inspect V1)
Locked (Trulicity Ifu Locked V1)
Figure (Trulicity Ifu Prepare V1)
Figure (Trulicity Ifu Remove V1)
Figure (Trulicity Ifu Sup 0point75 F2 V3)
Figure (Trulicity Ifu Sup 0point75 F3 V3)
Figure (Trulicity Ifu Sup 0point75 F4 V3)
Figure (Trulicity Ifu Sup 0point75 F5 V3)
Figure (Trulicity Ifu Sup 0point75 Pen Parts V3)
Figure (Trulicity Ifu Sup 0point75 Pen V3)
Figure (Trulicity Ifu Sup 1point5 F2 V3)
Figure (Trulicity Ifu Sup 1point5 F3 V3)
Figure (Trulicity Ifu Sup 1point5 F4 V3)
Figure (Trulicity Ifu Sup 1point5 F5 V3)
Figure (Trulicity Ifu Sup 1point5 Pen Parts V3)
Figure (Trulicity Ifu Sup 1point5 Pen V3)
Figure (Trulicity Ifu Sup 3mg F2 V1)
Figure (Trulicity Ifu Sup 3mg F3 V1)
Figure (Trulicity Ifu Sup 3mg F4 V1)
This text mentions the steps to determine if an injection is complete by observing the visibility of the gray plunger.*
Figure (Trulicity Ifu Sup 3mg F5 V1)
Figure (Trulicity Ifu Sup 3mg Pen Parts V1)
Figure (Trulicity Ifu Sup 3mg Pen V1)
Figure (Trulicity Ifu Sup 4point5 F2 V1)
Figure (Trulicity Ifu Sup 4point5 F3 V1)
Figure (Trulicity Ifu Sup 4point5 F4 V1)
Figure (Trulicity Ifu Sup 4point5 F5 V1)
Figure (Trulicity Ifu Sup 4point5 Pen Parts V1)
Figure (Trulicity Ifu Sup 4point5 Pen V1)
Figure (Trulicity Ifu Unfold V1)
Unlocked (Trulicity Ifu Unlock V1)
Figure 1 (Trulicity Pi F1 V2)
Figure 2 (Trulicity Pi F2 V2)
Figure 3 (Trulicity Pi F3 V3)
Figure 4 (Trulicity Pi F4 V3)
Figure 5 (Trulicity Pi F5 V2)
Figure 6 (Trulicity Pi F6 V2)
This text provides information about patients with an event (%), as well as the comparison between Placebo and Dulaglutide. The data includes percentages ranging from 10% to 20% for patients with an event. The text also mentions a hazard ratio (HR) of 0.88 and a 95% confidence interval (CI) of [0.79, 0.99] for Dulaglutide compared to Placebo. Additionally, it references a time of 6 years from randomization.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
